Rectal Adenocarcinoma clinical trials at UCSF
1 in progress, 1 open to new patients
open to eligible people ages 18 years and up
The investigators will be using the combination of FDG-PET and multiparametric MRI in pre- and post-adjuvant chemoradiation therapy in order to attempt to predict pathologic response on surgical resection.
San Francisco, California